Coexpression cluster:C2798
From FANTOM5_SSTAR
Full id: C2798_seminal_ductus_hippocampus_putamen_parietal_amygdala_caudate
Phase1 CAGE Peaks
| Hg19::chr4:95917409..95917421,+ | p11@BMPR1B |
| Hg19::chr5:131317011..131317016,- | p@chr5:131317011..131317016 - |
| Hg19::chr5:131335358..131335378,- | p3@ACSL6 |
| Hg19::chr5:131335380..131335396,- | p4@ACSL6 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
| GO ID | GO name | FDR corrected p-value |
|---|---|---|
| GO:0001550 | ovarian cumulus expansion | 0.00532783868959813 |
| GO:0048165 | fused antrum stage, oogenesis | 0.00532783868959813 |
| GO:0001547 | antral ovarian follicle growth | 0.00532783868959813 |
| GO:0022605 | oogenesis stage | 0.00532783868959813 |
| GO:0000287 | magnesium ion binding | 0.00625347626226086 |
| GO:0005025 | transforming growth factor beta receptor activity, type I | 0.0106550500303272 |
| GO:0015645 | fatty-acid ligase activity | 0.0112798249239386 |
| GO:0004467 | long-chain-fatty-acid-CoA ligase activity | 0.0112798249239386 |
| GO:0001502 | cartilage condensation | 0.0112798249239386 |
| GO:0046332 | SMAD binding | 0.0112798249239386 |
| GO:0006637 | acyl-CoA metabolic process | 0.0112798249239386 |
| GO:0048477 | oogenesis | 0.0112798249239386 |
| GO:0007405 | neuroblast proliferation | 0.0112798249239386 |
| GO:0030509 | BMP signaling pathway | 0.0112798249239386 |
| GO:0004675 | transmembrane receptor protein serine/threonine kinase activity | 0.0112798249239386 |
| GO:0005024 | transforming growth factor beta receptor activity | 0.0112798249239386 |
| GO:0001541 | ovarian follicle development | 0.0112798249239386 |
| GO:0022601 | menstrual cycle phase | 0.0118754373208547 |
| GO:0022602 | menstrual cycle process | 0.0118754373208547 |
| GO:0008585 | female gonad development | 0.0118754373208547 |
| GO:0009953 | dorsal/ventral pattern formation | 0.0118754373208547 |
| GO:0016877 | ligase activity, forming carbon-sulfur bonds | 0.0118754373208547 |
| GO:0046545 | development of primary female sexual characteristics | 0.0118754373208547 |
| GO:0046660 | female sex differentiation | 0.0118754373208547 |
| GO:0042698 | menstrual cycle | 0.0118754373208547 |
| GO:0043010 | camera-type eye development | 0.0118754373208547 |
| GO:0007292 | female gamete generation | 0.0118754373208547 |
| GO:0051216 | cartilage development | 0.0118754373208547 |
| GO:0060173 | limb development | 0.0118754373208547 |
| GO:0035107 | appendage morphogenesis | 0.0118754373208547 |
| GO:0035108 | limb morphogenesis | 0.0118754373208547 |
| GO:0048589 | developmental growth | 0.0118754373208547 |
| GO:0048736 | appendage development | 0.0118754373208547 |
| GO:0048731 | system development | 0.0118754373208547 |
| GO:0031903 | microbody membrane | 0.0122269174325372 |
| GO:0005778 | peroxisomal membrane | 0.0122269174325372 |
| GO:0044439 | peroxisomal part | 0.0122269174325372 |
| GO:0044438 | microbody part | 0.0122269174325372 |
| GO:0045597 | positive regulation of cell differentiation | 0.0122269174325372 |
| GO:0001654 | eye development | 0.0122269174325372 |
| GO:0048869 | cellular developmental process | 0.0122269174325372 |
| GO:0030154 | cell differentiation | 0.0122269174325372 |
| GO:0008406 | gonad development | 0.0125838056125745 |
| GO:0048608 | reproductive structure development | 0.0125838056125745 |
| GO:0048856 | anatomical structure development | 0.0135298304788747 |
| GO:0045137 | development of primary sexual characteristics | 0.0135298304788747 |
| GO:0048609 | reproductive process in a multicellular organism | 0.0135298304788747 |
| GO:0032504 | multicellular organism reproduction | 0.0135298304788747 |
| GO:0051094 | positive regulation of developmental process | 0.0147731056398816 |
| GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.0159343656977792 |
| GO:0004702 | receptor signaling protein serine/threonine kinase activity | 0.0159343656977792 |
| GO:0007275 | multicellular organismal development | 0.0159343656977792 |
| GO:0007548 | sex differentiation | 0.0161617906101618 |
| GO:0005741 | mitochondrial outer membrane | 0.0161617906101618 |
| GO:0007423 | sensory organ development | 0.0162435810661104 |
| GO:0003002 | regionalization | 0.0162435810661104 |
| GO:0003006 | reproductive developmental process | 0.0162435810661104 |
| GO:0031968 | organelle outer membrane | 0.0170629428085416 |
| GO:0019867 | outer membrane | 0.0173140632093917 |
| GO:0042579 | microbody | 0.0174431267736113 |
| GO:0005777 | peroxisome | 0.0174431267736113 |
| GO:0043235 | receptor complex | 0.0188751820253275 |
| GO:0007389 | pattern specification process | 0.0209354184380529 |
| GO:0019199 | transmembrane receptor protein kinase activity | 0.0211059568177126 |
| GO:0045595 | regulation of cell differentiation | 0.0235570851566974 |
| GO:0030145 | manganese ion binding | 0.0236824483250839 |
| GO:0005792 | microsome | 0.0257037987277299 |
| GO:0032502 | developmental process | 0.0258298488267971 |
| GO:0042598 | vesicular fraction | 0.02603453710581 |
| GO:0005057 | receptor signaling protein activity | 0.0268742409044643 |
| GO:0006631 | fatty acid metabolic process | 0.0285855311650691 |
| GO:0001501 | skeletal development | 0.0308368239405674 |
| GO:0005886 | plasma membrane | 0.0309517442921071 |
| GO:0032501 | multicellular organismal process | 0.0309517442921071 |
| GO:0050793 | regulation of developmental process | 0.0334143824400436 |
| GO:0048699 | generation of neurons | 0.0338100634234986 |
| GO:0022008 | neurogenesis | 0.0359262911726028 |
| GO:0007276 | gamete generation | 0.0359262911726028 |
| GO:0032787 | monocarboxylic acid metabolic process | 0.0381186699285198 |
| GO:0006732 | coenzyme metabolic process | 0.0381186699285198 |
| GO:0006954 | inflammatory response | 0.0381186699285198 |
| GO:0007167 | enzyme linked receptor protein signaling pathway | 0.0385177082049996 |
| GO:0009888 | tissue development | 0.0385177082049996 |
| GO:0022414 | reproductive process | 0.0385177082049996 |
| GO:0019953 | sexual reproduction | 0.0393067648118722 |
| GO:0051186 | cofactor metabolic process | 0.0422844170472928 |
| GO:0016337 | cell-cell adhesion | 0.0422844170472928 |
| GO:0031966 | mitochondrial membrane | 0.0491083704470924 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
| Motifs | -log10(p-value) |
|---|---|
| MA0003.1 | 0.0214529 |
| MA0004.1 | 0.71247 |
| MA0006.1 | 0.532262 |
| MA0007.1 | 0.6918 |
| MA0009.1 | 1.20602 |
| MA0014.1 | 0.0695829 |
| MA0017.1 | 0.577281 |
| MA0019.1 | 0.873355 |
| MA0024.1 | 1.09684 |
| MA0025.1 | 1.34373 |
| MA0027.1 | 2.83281 |
| MA0028.1 | 0.550763 |
| MA0029.1 | 1.11704 |
| MA0030.1 | 1.10506 |
| MA0031.1 | 1.03735 |
| MA0038.1 | 0.824639 |
| MA0040.1 | 1.12314 |
| MA0041.1 | 0.732902 |
| MA0042.1 | 0.697662 |
| MA0043.1 | 1.20635 |
| MA0046.1 | 1.19471 |
| MA0048.1 | 0.25531 |
| MA0050.1 | 0.69864 |
| MA0051.1 | 0.820063 |
| MA0052.1 | 1.12718 |
| MA0055.1 | 0.125954 |
| MA0056.1 | 0 |
| MA0057.1 | 0.248209 |
| MA0058.1 | 0.605914 |
| MA0059.1 | 0.604454 |
| MA0060.1 | 0.393285 |
| MA0061.1 | 0.360128 |
| MA0063.1 | 0 |
| MA0066.1 | 0.825101 |
| MA0067.1 | 1.53181 |
| MA0068.1 | 0.313194 |
| MA0069.1 | 1.19071 |
| MA0070.1 | 1.17908 |
| MA0071.1 | 0.782546 |
| MA0072.1 | 1.1744 |
| MA0073.1 | 0.214613 |
| MA0074.1 | 0.819248 |
| MA0076.1 | 0.623864 |
| MA0077.1 | 1.16637 |
| MA0078.1 | 0.926725 |
| MA0081.1 | 0.604638 |
| MA0083.1 | 1.21381 |
| MA0084.1 | 1.72172 |
| MA0087.1 | 1.17185 |
| MA0088.1 | 0.536981 |
| MA0089.1 | 0 |
| MA0090.1 | 0.640115 |
| MA0091.1 | 0.715356 |
| MA0092.1 | 1.6149 |
| MA0093.1 | 0.535768 |
| MA0095.1 | 0 |
| MA0098.1 | 0 |
| MA0100.1 | 0.83965 |
| MA0101.1 | 0.539569 |
| MA0103.1 | 0.521546 |
| MA0105.1 | 0.232357 |
| MA0106.1 | 0.869173 |
| MA0107.1 | 0.453492 |
| MA0108.2 | 1.03412 |
| MA0109.1 | 0 |
| MA0111.1 | 1.57689 |
| MA0113.1 | 0.886811 |
| MA0114.1 | 0.447443 |
| MA0115.1 | 1.45393 |
| MA0116.1 | 0.457606 |
| MA0117.1 | 1.24497 |
| MA0119.1 | 3.57466 |
| MA0122.1 | 1.27173 |
| MA0124.1 | 1.41151 |
| MA0125.1 | 1.32534 |
| MA0130.1 | 0 |
| MA0131.1 | 0.94608 |
| MA0132.1 | 0 |
| MA0133.1 | 0 |
| MA0135.1 | 1.23748 |
| MA0136.1 | 0.832277 |
| MA0139.1 | 0.344952 |
| MA0140.1 | 0.779643 |
| MA0141.1 | 0.602484 |
| MA0142.1 | 1.00381 |
| MA0143.1 | 0.887001 |
| MA0144.1 | 0.430413 |
| MA0145.1 | 0.195821 |
| MA0146.1 | 0.221129 |
| MA0147.1 | 0.46175 |
| MA0148.1 | 0.739888 |
| MA0149.1 | 0.769072 |
| MA0062.2 | 0.353589 |
| MA0035.2 | 0.778873 |
| MA0039.2 | 0.777367 |
| MA0138.2 | 0.928035 |
| MA0002.2 | 0.98779 |
| MA0137.2 | 0.558189 |
| MA0104.2 | 0.392359 |
| MA0047.2 | 0.856092 |
| MA0112.2 | 0.187982 |
| MA0065.2 | 1.09513 |
| MA0150.1 | 0.633493 |
| MA0151.1 | 0 |
| MA0152.1 | 0.78681 |
| MA0153.1 | 1.30799 |
| MA0154.1 | 0.649108 |
| MA0155.1 | 0.180766 |
| MA0156.1 | 0.560797 |
| MA0157.1 | 0.97481 |
| MA0158.1 | 0 |
| MA0159.1 | 0.462502 |
| MA0160.1 | 0.756582 |
| MA0161.1 | 0 |
| MA0162.1 | 0.0928415 |
| MA0163.1 | 1.90765 |
| MA0164.1 | 0.90014 |
| MA0080.2 | 0.535868 |
| MA0018.2 | 0.870662 |
| MA0099.2 | 0.7872 |
| MA0079.2 | 0.00910927 |
| MA0102.2 | 1.75932 |
| MA0258.1 | 0.418966 |
| MA0259.1 | 0.471671 |
| MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.
